[ad_1]
Already negative on the file, the broker JP Morgan maintains its advice to sell. The target price remains unchanged at 48.70 EUR.
Zonebourse with dpa-AFX Analyzer 2022 All the news about FRESENIUS MEDICAL CARE AG & CO. KGAA |
| | |
Analyst Recommendations for FRESENIUS MEDICAL CARE AG & CO. KGAA |
| | |
| | 2021 turnover |
20,198M
–
17,707M | 2021 net result |
1,209M
–
1,060M | Net debt 2021 |
12,933M
–
11,338M | PER 2021 | 16.4x | 2021 performance | 2.01% |
| Capitalization |
19,718m
19,732M
17,285M | VE / CA 2021 | 1.62x | VE / CA 2022 | 1.51x | Number of employees | 123,528 | Floating | – |
|
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA |
| Hard :
Period:
|
| |
Trends technical analysis FRESENIUS MEDICAL CARE AG & CO. KGAA | Short term | Middle term | Long term | Trends | bullish | Bearish | Bearish |
Evolution of the Income Statement | Average recommendation | ACCUMULATE | Number of Analysts | 20 | Last Closing Price | $67.30 | Average price target | $76.57 | Deviation / Average Target |
13.8% |
| [ad_2]
Source link -88